newsfilter
← Latest News
Business Wire·

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S.